Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial-Reference-Cited by-同舟云学术

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Published:2017-09-19 Issue:9 Volume:14 Page:e1002388
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Canfell Karen,Caruana Michael^ORCID,Gebski Val,Darlington-Brown Jessica^ORCID,Heley Stella,Brotherton Julia,Gertig Dorota,Jennett Chloe J.,Farnsworth Annabelle,Tan Jeffrey^ORCID,Wrede C. David^ORCID,Castle Philip E.,Saville Marion

Funder

The Victorian Cytology Service (VCS) Ltd

Roche Molecular Systems

Roche Tissue Diagnostics, AZ USA

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference27 articles.

1. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials;G Ronco;Lancet,2014

2. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial;G Ronco;Lancet Oncol,2010

3. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial;DC Rijkaart;Lancet Oncol,2012